PulseTrendingJournal ClubResearchersJournalsExplore
Instagram
HomeTrendingJournal ClubExplore
Synapse
⌘+K
Synapse
October 10, 2024Netherlands Heart JournalOpen Access

Moving towards a uniform diagnosis of coronary artery disease on coronary CTA

View Full Paper
Ask AI
Bookmark
Share

Design

Review

Key result

The CAD-RADS 2.0 standardized reporting system for coronary CTA incorporates plaque burden, ischemia, and high-risk plaque modifiers to improve communication and guide therapeutic management.

Authors

CCCsilla CelengRTRichard A. P. Takx

Discussion

Loading...

Member takes

Overview

CAD-RADS 2.0 may standardize coronary CTA reporting; leaves open prospective outcome validation before routine adoption.

PICO

P
Population
Coronary Artery Disease
I
Intervention / Comparator
CAD-RADS 2.0

The adoption of CAD-RADS 2.0 for coronary CTA reporting standardizes diagnosis, incorporates plaque burden and ischemia, and is crucial for uniform patient management.

Limitations

  • Plaque burden can be determined using various techniques, leading to potential variability in scoring.
  • CAD-RADS 2.0 omits the segregation of more proximal versus distal stenosis, despite proximal plaques having a higher event rate.
  • The inclusion of high-risk plaque (HRP) modifiers is debatable due to fair to moderate inter-rater reliability and limited prognostic value.
  • CAD-RADS might underestimate the progression of coronary sclerosis on follow-up CCTAs compared to segment stenosis and involvement scores.
  • Plaque burden can be determined using various techniques
  • Omits segregation of proximal versus distal stenosis
  • High-risk plaque modifier has fair to moderate inter-rater reliability
  • May underestimate progression of coronary sclerosis on follow-up

Cite This Study

Celeng et al. (2024) conducted a review in Coronary Artery Disease. CAD-RADS 2.0 was evaluated. The CAD-RADS 2.0 standardized reporting system for coronary CTA incorporates plaque burden, ischemia, and high-risk plaque modifiers to improve communication and guide therapeutic management.

synapsesocial.com/papers/6a154fe5b2e0231f15824572https://doi.org/10.1007/s12471-024-01903-6
View Full Paper
Ask AI
Bookmark
Share